Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical agents and erectile dysfunction: is there a place?

Ronald L Yap1, Kevin T McVary

  • 1Department of Urology, Northwestern University Medical School, Tarry 11-725, 303 East Chicago Avenue, Chicago, IL 60611, USA.

Current Urology Reports
|November 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional differences in corpora cavernosa morphology exist along the proximal to distal axis of the penis in adult Sprague Dawley rats.

The journal of sexual medicine·2026
Same author

Targeting fibrosis in the treatment of lower urinary tract dysfunction.

The Journal of pathology·2026
Same author

Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia.

Prostate cancer and prostatic diseases·2026
Same author

Sexual function outcomes of the 5-year treatment with Rezum compared to doxazosin, finasteride, and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of Prostatic Symptoms Trial.

The journal of sexual medicine·2026
Same author

Mitochondrial dysfunction in urologic disease.

Prostate cancer and prostatic diseases·2026
Same author

A systematic review of associations-exploring whether prostate size is related to sexual function outcomes following water vapor thermal therapy.

Sexual medicine reviews·2026

Topical treatments offer a minimally invasive option for erectile dysfunction (ED) when oral medications fail or cause drug interactions. Further research is needed to overcome challenges for these promising ED therapies.

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Oral therapies are effective for erectile dysfunction (ED), but contraindications like drug interactions (e.g., sildenafil with nitroglycerin) and lack of response limit their use for some patients.
  • Topical agents present a minimally invasive alternative for ED treatment, offering a different therapeutic avenue.

Purpose of the Study:

  • To review the challenges and impediments hindering the effective use of topical agents for ED.
  • To examine the current developmental status of various candidate topical drugs for ED treatment.

Main Methods:

  • This study is a review of existing literature on topical ED treatments.
  • It analyzes the obstacles to successful topical therapy and the progress of drug development.

Main Results:

Related Experiment Videos

  • Several topical drug candidates for ED are under investigation.
  • Impediments to effective topical therapy have been identified.

Conclusions:

  • Topical medications are still in the investigative stage for ED treatment.
  • These agents have the potential to become a valuable addition to the urologist's treatment options for ED.